Completed
The drug development process faces challenges of efficiency and overall sustainability due in part to high research costs, lengthy development timelines, and late-stage drug failures. Novel clinical trial designs that target genetically identified participants represent a potentially disruptive paradigm shift that could reduce costs associated with drug development, improve patient outcomes, and further realize the goals of precision medicine. This workshop examined later stages in the drug development pipeline, including the design and implementation of genetics-based clinical trials.
Discover
Events
Right Now & Next Up
Stay in the loop with can’t-miss sessions, live events, and activities happening over the next two days.
NAS Building Guided Tours Available!
Participate in a one-hour guided tour of the historic National Academy of Sciences building, highlighting its distinctive architecture, renowned artwork, and the intersection of art, science, and culture.